Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients

Clinical Chemistry

Volumn 62, Issue 4, 2016, Pages 631-638

  Sandoval, Yader ^a   Herzog, Charles A ^a,b   Love, Sara A ^a,c   Cao, Jing ^c   Hu, Yan ^b   Wu, Alan H B ^d   Gilbertson, David ^b   Brunelli, Steven M ^e   Young, Amy ^e   Ler, Ranka ^c   Apple, Fred S ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DAVITA CLINICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; END STAGE RENAL DISEASE; FOLLOW UP; HAZARD RATIO; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; QUALITY CONTROL; REFERENCE CHANGE VALUE; REFERENCE VALUE; SUDDEN CARDIAC DEATH; BLOOD; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; FEMALE; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; LIMIT OF DETECTION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; STATISTICS AND NUMERICAL DATA; TRENDS;

CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LIMIT OF DETECTION; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RENAL DIALYSIS; TROPONIN I; TROPONIN T;

EID: 84962434243     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.251835     Document Type: Article

References (25)

1. Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med 2010;363:1833-45.
2. U.S. Renal Data System. USRDS 2014 Annual data report: atlas of end-stage renal disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases; 2014.
3. Wan C, Herzog CA, Zareba W, Szymkiewicz SJ. Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol 2014;19:247-57.
4. Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008;21:300-7.
5. Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011;80:572-86.
6. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106:2941-5.
7. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarkerrisk stratification of N-terminal pro-B-typenatriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50:2279-85.
8. Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
9. Korley FK, Jaffe AS. Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol 2013;61:1753-8.
10. Apple FS, Hollander J, Wu AH, Jaffe AS. Improving the 510(k) FDA process for cardiac troponin assays: in search of common ground. Clin Chem 2014;60: 1273-5.
11. Apple FS, Ler R, Love SA, Hu Y, Gilbertson D, Murakami MM, et al. High sensitivity cardiac troponin I and T assays for predicting death ina hemodialysis population. Clin Chem 2015;61:S125. Abstract B-016.
12. Fahim MA, Hayen AD, Horvath AR, Dimeski G, Coburn A, Tan KS, et al. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med 2015;53: 715-22.
13. Aakre KM, Røraas T, Petersen PH, Svarstad E, Sellevoll H, Skadberg Ø, et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin Chem 2014;60:838-47.
14. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.
15. Fraser CG. Biological variation: from principles to practice. Washington (DC): AACC Press; 2001.
16. Wu AH. Biological and analytical variation of clinical biomarker testing: implications for biomarker-guided therapy. Curr Heart Fail Rep 2013;10:434-40.
17. Hassan HC, Howlin K, Jefferys A, Spicer ST, Aravindan AN, Suryanarayanan G, et al. A. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clin Chem 2014;60: 389-98.
18. Wu AH, Akhigbe P, Wians F. Long-term biological variation in cardiac troponin I. Clin Biochem 2012;45: 714-6.
19. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I measuredwithahigh-sensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-8.
20. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004;65:2380-9.
21. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-48.
22. Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, et al. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. J Am Heart Assoc 2014;17:e001363.
23. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124:136-45.
24. Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209-18.
25. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.